Analytical Chemist
Analytical Chemist
Send Message
Analytical Chemist
Stop FollowingAnalytical Chemist
View as an RSS Feed
View Analytical Chemist's Articles BY TICKER:
- Apple: The Dangers Of Using Bad Data To Calculate Only One Metric
- Why I Bought Linn Energy In My Roth IRA
- An Attractive Arbitrage Opportunity In Supervalu
-
It Doesn't Matter Where Returns Come From: More Realistic Modeling Of Dividend Growth Investing
on Sat, Sep 29, 2012 • 49 Comments - Booking First Class, Stuck In Steerage: Beware The Dangers Of Dual-Class Stocks
- Supervalu Shorts Still Don't Get It
- Pfizer's Declining R&D: Count Me Out
- Misleading Payout Ratios In Emerging Market Telecoms
-
Visualizing Dividend Growth Rates
- Supervalu Is Drastically Undervalued
- DUSA Pharmaceuticals, Up 25% Tuesday, Still Has Room To Run
- Misleading Dividend Payout Ratios In Small-Cap Telecom Stocks
- Misleading Payout Ratios In International Telecommunications Stocks
- Misleading Dividend Payout Ratios In Telecommunications Stocks
- 3 Paths For Dendreon As Provenge Plods Toward Profits
- Street Overreacts To Supervalu Earnings; Provides Attractive Buy Opportunity
- Pfizer Out Of Lipitor's Shadow, But Still Expects To Grow Profits
- Transocean Ruling May Limit Oil Spill Liability
- Amylin's Agreement with Lilly Will Not Lead It To Profitablity
- Transocean Receives Favorable Ruling On Liability
- Focus On Berkshire's Q3 Operating Earnings
- An In-Depth Look At Berkshire Hathaway, Part 3: Burlington Northern Santa Fe
- Will Abbott's Split Unlock Shareholder Value?
- An In-Depth Look At Berkshire Hathaway, Part 2: Utilities And Energy
- Oil Companies In Libya
- Assessing EWZ: Brazilian Stocks Appear Undervalued
- Dendreon and Provenge: Too High of a Risk for the Reward
- An In-Depth Look at Berkshire Hathaway, Part 1: Insurance
- Teva's Acquisition of Cephalon Is Another Buy Sign
- Teva's Bad News Presents Buying Opportunity
- Beyond Provenge: Dendreon Is Too Expensive for Value, Growth Investors
- Intel's Q1 Proves It Doesn't Need Mobile Chip Sales
